We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The number of technology and life sciences companies going public increased 62 percent in 2013, showing a “very strong” IPO market that took off in the second quarter, according to a survey by law firm Fenwick & West. Read More
Irish devicemaker Covidien is voluntarily recalling certain lots of its Pipeline Embolization Device and Alligator Retrieval Device over concerns a coating applied to the delivery wire could detach from the devices. Read More
There has been a steady uptick in the number of FDA 483s that cite inadequate supplier controls — from 84 in 2011, to 110 in 2012 and 126 last year. Read More